Discover how dihydroartemisinin (DHA), derived from ancient antimalarial plants, targets PDGFRα in aggressive ovarian cancer, offering new hope against this lethal disease.
Discover how targeting neddylation with MLN4924 could overcome cisplatin resistance in ovarian cancer, offering new hope for patients with recurrent disease.